Auto Amazon Links: No products found.
A review conducted in 2022 revealed alarmingly high mortality rates associated with liver and pancreas surgeries performed by NHS Grampian. Specifically, the investigation showed that between 2017 and 2020, the death rate after major liver resections was 12% at 30 days and rose to 18% at 90 days. This starkly contrasted with the expected mortality rate of just 2.2%. The report highlighted concerns about the clinical decisions, noting that liver surgeries were sometimes pursued with an “overly aggressive” approach, including operations proceeding even when the disease was considered inoperable.
In regard to pancreatic surgery, the experts pointed out a troubling pattern where patients were frequently rushed into the operating theater without sufficient planning or adequate evaluation of non-surgical treatment options. Both types of surgery were further criticized for “unacceptably high” blood loss during procedures. The review also identified significant shortcomings in leadership and the absence of clear protocols for preoperative planning. Despite predictions of elevated mortality risks, poor clinical judgment and aggressive surgical strategies persisted.
An earlier report published earlier in the same year echoed these criticisms, emphasizing recurring issues around poor risk assessment and numerous incidents of major blood loss and fatal outcomes during and after surgeries. It described these problems as “long standing and recurrent,” noting that NHS Grampian had made attempts to improve results but failed to implement necessary structural reforms. The report also underscored the shortage of specialist staff capable of safely delivering complex hepatopancreatobiliary (HPB) surgery. Persistent concerns raised since 2010 had yet to be adequately addressed. As a result, the review strongly recommended that no complex or major HPB surgeries should continue at Aberdeen Royal Infirmary.
Dr. Habib, a consultant with experience in General Surgery and HPB since 2014, expressed his concern that several hundred patients had suffered harm due to a high rate of complications. He stated that despite utilizing whistleblowing channels, the institutions he approached failed to take decisive action. He first became aware of avoidable deaths related to surgery in 2016 and formally raised serious concerns in July 2021, citing dozens of preventable fatalities. In February 2024, he reported the matter to Police Scotland. Dr. Habib accused NHS Grampian of demonstrating “wicked recklessness and an indifference to patient deaths,” calling for a corporate homicide investigation.
According to Dr. Habib, a confidential 2022 expert report found that 19 out of 45 deaths examined in a case study, representing 42%, were avoidable. Since June 2023, he had reached out multiple times to the First Minister and Health Secretary, but the Scottish Government claimed it lacked the authority to investigate whistleblowing allegations. Additionally, the Independent Whistleblowing Officer (INWO) declined to advance his complaints. In December 2025, Dr. Habib contacted NHS Grampian’s Chief Executive, Laura Skaife Knight, who responded by urging patience for ongoing Healthcare Improvement Scotland (HIS) enquiries and indicated she had no further comments at that time. Dr. Habib criticized this response, stating, “They are avoiding accountability by not being transparent about what damage has been done, while promising heaven and earth going forward.
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found.